Emerald Mutual Fund Advisers Trust’s Tempest Therapeutics TPST Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-114	Closed	-$2.82M	–	295
2015 Q3	$2.82M	Buy	114 +97	+571%	+$6.53M	0.18%	139
2015 Q2	$1.42M	Buy	+17	New	+$1.56M	0.11%	154
2015 Q1	–	Sell	-29	Closed	-$3.73M	–	233
2014 Q4	$3.73M	Sell	29 -46	-61%	-$3.37M	0.32%	96
2014 Q3	$3.66M	Hold	75	–	–	0.35%	94
2014 Q2	$2.02M	Buy	75 +29	+63%	+$684K	0.19%	122
2014 Q1	$1.2M	Buy	+46	New	+$1.3M	0.12%	144

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TPST Position: Q4 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Tempest Therapeutics (TPST) in Q4 2015, closing a stake of 114 shares — an estimated $2.82M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TPST in Q1 2014 and held it in 6 quarters. The position peaked at $3.73M in Q4 2014. 78 funds tracked by Wall St. Rank hold TPST as of Q4 2015.

Emerald Mutual Fund Advisers Trust reported no remaining Tempest Therapeutics position as of Q4 2015 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 114 Tempest Therapeutics shares in Q4 2015, an estimated $2.82M.
Emerald Mutual Fund Advisers Trust first reported a position in Tempest Therapeutics in Q1 2014 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's Tempest Therapeutics position peaked at $3.73M in Q4 2014.
78 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2015, filed 25 Jan 2016.